Overview
US diversified holding company reported Q4 revenue up 61.7% yr/yr, driven by Infrastructure segment
Q4 net loss narrowed to $7.8 mln from $16.9 mln a year earlier
Adjusted EBITDA for Q4 rose to $24.5 mln from $15.0 mln yr/yr
Outlook
Company says DBMG backlog of $1.8 bln supports revenue visibility for 2026
Life Sciences expects additional MediBeacon system placements as inventory builds
Spectrum segment expects network launches to deliver benefits beginning in 2026
Result Drivers
INFRASTRUCTURE PROJECTS - Q4 revenue growth was primarily driven by increased activity and the timing and size of large projects at DBMG's commercial structural steel fabrication and erection business
BACKLOG GROWTH - DBMG adj. backlog rose to $1.8 bln, supporting future revenue visibility, as DBMG reported strong bookings and operating momentum
SEGMENT WEAKNESS - Spectrum revenue declined due to customer terminations and advertising market softness; Life Sciences segment saw lower R2 unit sales in North America
Company press release: ID:nGNX2QRWNM
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue |
| $382.70 mln |
|
Q4 EPS |
| -$0.58 |
|
Q4 Net Income |
| -$7.80 mln |
|
Q4 Adjusted EBITDA |
| $24.50 mln |
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.